Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans

Journal of Clinical Investigation

Volumn 117, Issue 4, 2007, Pages 919-930

  Van Wesenbeeck, Liesbeth ^a   Odgren, Paul R ^b   Coxon, Fraser P ^c   Frattini, Annalisa ^d   Moens, Pierre ^e   Perdu, Bram ^a   MacKay, Carole A ^b   Van Hul, Els ^a   Timmermans, Jean Pierre ^a   Vanhoenacker, Filip ^f   Jacobs, Ruben ^e   Peruzzi, Barbara ^g   Teti, Anna ^g   Helfrich, Miep H ^c   Rogers, Michael J ^c   Villa, Anna ^d   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d CNR   (Italy)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PLECKSTRIN; PROTEIN PLEKHM1; RAB7 PROTEIN; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRANSPORT VESICLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MALE; MEMBRANE GLYCOPROTEINS; MONOCYTES; MUTATION; ORGAN SPECIFICITY; OSTEOPETROSIS; PEDIGREE; RAB GTP-BINDING PROTEINS; RATS;

EID: 34147150205     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30328     Document Type: Article

References (69)

1. Balemans, W., Van Wesenbeeck, L., and Van Hul, W. 2005. A clinical and molecular overview of the human osteopetroses. Calcif. Tissue Int. 77:263-274.
2. Sly, W.S., Hewett-Emmett, D., Whyte, M.P., Yu, Y.S., and Tashian, R.E. 1983. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. U. S. A. 80:2752-2756.
3. Kornak, U., et al. 2000. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9:2059-2063.
4. Frattini, A., et al. 2000. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25:343-346.
5. Kornak, U., et al. 2001. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 104:205-215.
6. Cleiren, E., et al. 2001. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 10:2861-2867.
7. Campos-Xavier, A.B., Saraiva, J.M., Ribeiro, L.M., Munnich, A., and Cormier-Daire, V. 2003. Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum. Genet. 112:186-189.
8. Chalhoub, N., et al. 2003. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat. Med. 9:399-406.
9. Ramirez, A., et al. 2004. Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Hum. Mutat. 23:471-476.
10. Quarello, P., et al. 2004. Severe malignant osteopetrosis caused by a gl gene mutation. J. Bone Miner. Res. 19:1194-1199.
11. Pangrazio, A., et al. 2006. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J. Bone Miner. Res. 21:1098-1105.
12. Lange, P.F., Wartosch, L., Jentsch, T.J., and Fuhrmann, J.C. 2006. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature. 440:220-223.
13. Van Wesenbeeck, L., and Van Hul, W. 2005. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology. Crit. Rev. Eukaryot. Gene Expr. 15:133-162.
14. Greep, R.O. 1941. An hereditary absence of the incisors teeth. J. Hered. 32:397-398.
15. Reinholt, F.P., et al. 1999. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function. Exp. Cell Res. 251:477-491.
16. Marks, S.C., Jr. 1973. Pathogenesis of osteopetrosis in the ia rat: reduced bone resorption due to reduced osteoclast function. Am. J. Anat. 138:165-189.
17. Marks, S.C., Jr. 1976. Osteopetrosis in the ia rat cured by spleen cells from a normal littermate. Am. J. Anat. 146:331-338.
18. Miller, S.C., and Marks, S.C., Jr. 1982. Osteoclast kinetics in osteopetrotic (ia) rats cured by spleen cell transfers from normal littermates. Calcif. Tissue Int. 34:422-427.
19. Marks, S.C., Jr. 1978. Studies of the mechanism of spleen cell cure for osteopetrosis in ia rats: appearance of osteoclasts with ruffled borders. Am. J. Anat. 151:119-129.
20. Van Wesenbeeck, L., Odgren, P.R., Mackay, C.A., and Van Hul, W. 2004. Localization of the gene causing the osteopetrotic phenotype in the incisors absent (ia) rat on chromosome 10q32.1. J. Bone Miner. Res. 19:183-189.
21. Raber, S.A. 1999. The dense metaphyseal band sign. Radiology. 211:773-774.
22. Jurdic, P., Saltel, F., Chabadel, A., and Destaing, O. 2006. Podosome and sealing zone: specificity of the osteoclast model. Eur. J. Cell Biol. 85:195-202.
23. Hartel-Schenk, S., et al. 2001. Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway. Glycoconj. J. 18:915-923.
24. Bendtsen, J.D., Nielsen, H., von Heijne, G., and Brunak, S. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
25. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E.L. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580.
26. Mulder, N.J., et al. 2003. The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res. 31:315-318.
27. Lorick, K.L., et al. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 96:11364-11369.
28. Ono, Y., et al. 1989. Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc. Natl. Acad. Sci. U. S. A. 86:4868-4871.
29. Callebaut, I., de Gunzburg, J., Goud, B., and Mornon, J.P. 2001. RUN domains: a new family of domains involved in Ras-like GTPase signaling. Trends Biochem. Sci. 26:79-83.
30. Bayer, M., et al. 2005. Identification and characterization of Iporin as a novel interaction partner for rab1. BMC Cell Biol. 6:15.
31. Janoueix-Lerosey, I., Jollivet, F., Camonis, J., Marche, P.N., and Goud, B. 1995. Two-hybrid system screen with the small GTP-binding protein Rab6. Identification of a novel mouse GDP dissociation inhibitor isoform and two other potential partners of Rab6. J. Biol. Chem. 270:14801-14808.
32. Janoueix-Lerosey, I., Pasheva, E., de Tand, M.F., Tavitian, A., and de Gunzburg, J. 1998. Identification of a specific effector of the small GTP-binding protein Rap2. Eur. J. Biochem. 252:290-298.
33. Yang, J., Kim, O., Wu, J., and Qiu, Y. 2002. Interaction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle trafficking. J. Biol. Chem. 277:30219-30226.
34. Mari, M., Macia, E., Le Marchand-Brustel, Y., and Cormont, M. 2001. Role of the FYVE finger and the RUN domain for the subcellular localization of Rabip4. J. Biol. Chem. 276:42501-42508.
35. Cozier, G.E., Carlton, J., Bouyoucef, D., and Cullen, P.J. 2004. Membrane targeting by pleckstrin homology domains. Curr. Top. Microbiol. Immunol. 282:49-88.
36. Lemmon, M.A. 2004. Pleckstrin homology domains: not just for phosphoinositides. Biochem. Soc. Trans. 32:707-711.
37. Maghazachi, A.A. 2000. Intracellular signaling events at the leading edge of migrating cells. Int. J. Biochem. Cell Biol. 32:931-943.
38. Lemmon, M.A., Ferguson, K.M., and Abrams, C.S. 2002. Pleckstrin homology domains and the cytoskeleton. FEBS Lett. 513:71-76.
39. Ingley, E., and Hemmings, B.A. 1994. Pleckstrin homology (PH) domains in signal transduction. J. Cell. Biochem. 56:436-443.
40. Johansson, M., Lehto, M., Tanhuanpaa, K., Cover, T.L., and Olkkonen, V.M. 2005. The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. Mol. Biol. Cell. 16:5480-5492.
41. Bucci, C., Thomsen, P., Nicoziani, P., McCarthy, J., and van Deurs, B. 2000. Rab7: a key to lysosome biogenesis. Mol. Biol. Cell. 11:467-480.
42. Mesa, R., Salomon, C., Roggero, M., Stahl, P.D., and Mayorga, L.S. 2001. Rab22a affects the morphology and function of the endocytic pathway. J. Cell Sci. 114:4041-4049.
43. Barbieri, M.A., Li, G., Mayorga, L.S., and Stahl, P.D. 1996. Characterization of Rab5:Q79L-stimulated endosome fusion. Arch. Biochem. Biophys. 326:64-72.
44. Bucci, C., et al. 1992. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 70:715-728.
45. Goud, B., Zahraoui, A., Tavitian, A., and Saraste, J. 1990. Small GTP-binding protein associated with Golgi cisternae. Nature. 345:553-556.
46. Vitelli, R., et al. 1997. Role of the small GTPase Rab7 in the late endocytic pathway. J. Biol. Chem. 272:4391-4397.
47. Meresse, S., Gorvel, J.P., and Chavrier, P. 1995. The rab7 GTPase resides on a vesicular compartment connected to lysosomes. J. Cell Sci. 108:3349-3358.
48. Feng, Y., Press, B., and Wandinger-Ness, A. 1995. Rab 7: an important regulator of late endocytic membrane traffic. J. Cell Biol. 131:1435-1452.
49. Lombardi, D., et al. 1993. Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J. 12:677-682.
50. Casey, P.J., and Seabra, M.C. 1996. Protein prenyltransferases. J. Biol. Chem. 271:5289-5292.
51. Coxon, F.P., et al. 2001. Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J. Biol. Chem. 276:48213-48222.
52. Ceresa, B.P., and Bahr, S.J. 2006. rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J. Biol. Chem. 281:1099-1106.
53. Vaananen, K. 2005. Mechanism of osteoclast mediated bone resorption - rationale for the design of new therapeutics. Adv. Drug Deliv. Rev. 57:959-971.
54. Del Fattore, A., et al. 2006. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J. Med. Genet. 43:315-325.
55. Taranta, A., et al. 2003. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am. J. Pathol. 162:57-68.
56. Palokangas, H., Mulari, M., and Vaananen, H.K. 1997. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in boneresorbing osteoclasts. J. Cell Sci. 110:1767-1780.
57. Coxon, F.P., and Rogers, M.J. 2003. The role of prenylated small GTP-binding proteins in the regulation of osteoclast function. Calcif. Tissue Int. 72:80-84.
58. Pavlos, N.J., et al. 2005. Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol. Cell. Biol. 25:5253-5269.
59. Zhao, H., Laitala-Leinonen, T., Parikka, V., and Vaananen, H.K. 2001. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem. 276:39295-39302.
60. Pfeffer, S. 2005. A model for Rab GTPase localization. Biochem. Soc. Trans. 33:627-630.
61. Pfeffer, S., and Aivazian, D. 2004. Targeting Rab GTPases to distinct membrane compartments. Nat. Rev. Mol. Cell Biol. 5:886-896.
62. Coxon, F.P., et al. 2005. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo. Bone. 37:349-358.
63. Cantalupo, G., Alifano, P., Roberti, V., Bruni, C.B., and Bucci, C. 2001. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 20:683-693.
64. Mizuno, K., Kitamura, A., and Sasaki, T. 2003. Rabring7, a novel Rab7 target protein with a RING finger motif. Mol. Biol. Cell. 14:3741-3752.
65. Sun, Y., Buki, K.G., Ettala, O., Vaaraniemi, J.P., and Vaananen, H.K. 2005. Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J. Biol. Chem. 280:32356-32361.
66. Dunford, J.E., Rogers, M.J., Ebetino, F.H., Phipps, R.J., and Coxon, F.P. 2006. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases. J. Bone Miner. Res. 21:684-694.
67. Thompson, K., Rogers, M.J., Coxon, F.P., and Crockett, J.C. 2006. Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluidphase endocytosis. Mol. Pharmacol. 69:1624-1632.
68. van't Hof, R.J., Tuinenburg-Bol Raap, A.C., and Nijweide, P.J. 1995. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3. Int. J. Exp. Pathol. 76:205-214.
69. Taylor, A., Rogers, M.J., Tosh, D., and Coxon, F.P. 2007. A novel method for efficient generation of transfected human osteoclasts. Calcif. Tissue Int. 80:132-136.